TCL Archive In Brief: Hellman To Head DCT board; Gard Joins Colorado Group; NCI May Support Death Index September 12, 1980
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive DCT Advisors Approve $22 Mil. Set Aside For Interactive R01s Systemic Therapies July 10, 1992
TCL Archive Is a New Cancer Center Always a Good Thing? UCSD To Buy Las Vegas Center at Bankruptcy Sale January 20, 2012
